Skip to main content
. 2009 Nov 10;10(11):R127. doi: 10.1186/gb-2009-10-11-r127

Table 3.

Characteristics of patients in the independent test set 1

Sample ID Age (years) Sex Bacterial isolation Antibiotherapy before blood collection Underlying diseases Survival
Other sepsis (n = 11)
 I016* † 61 Female Coagulase-negative staphylococci Ceftazidime, bactrim, Sulperazole Hematemesis Survivor
 I017* ‡§ 50 Male Coagulase-negative staphylococci Ceftriaxone, ceftazidime, doxycycline, cloxacillin Acute pancreatitis, nephrotic syndrome Survivor
 I018§¶¥ 57 Male Coagulase-negative staphylococci# Vancomycin T2D, CRF Survivor
 I019¤ 58 Female Staphylococcus aureus Cloxacillin, ceftazidime T2D, wound Survivor
 I020¶¥ 66 Female Coagulase-negative staphylococci# Ceftazidime, ceftriaxone T2D, ARF, tuberculosis Non-survivor
 I021 54 Female Enterococcus spp. Ceftazidime, cloxacilin T2D, abscess Non-survivor
 I022§¶ 37 Male Coagulase-negative staphylococci# Ceftriaxone, ceftazidime T2D, ARF Non-survivor
 I023¶¤ 70 Female E. coli Doxycycline, ceftazidime T2D Non-survivor
 I024¶¥ 56 Male Coagulase-negative staphylococci Meropenem, ceftazidime T2D, RF Survivor
 I025* 50 Male S. pneumoniae Ceftriaxone, meropenem T2D Non-survivor
 I026 57 Male K. pneumoniae Ceftriaxone, ceftazidime, bactrim T2D Survivor
Septicemic melioidosis (n = 13)
 M016 39 Male B. pseudomallei Ceftazidime, bactrim, doxycycline T2D Survivor
 M017 52 Female B. pseudomallei Norfloxacin, ceftazolin T2D Survivor
 M020 61 Male B. pseudomallei Ceftriaxone, doxycycline, ceftazidime - Survivor
 M021 56 Female B. pseudomallei Ceftriaxone, ceftazidime T2D Survivor
 M022 18 Male B. pseudomallei Ceftazidime, cactrim T2D Survivor
 M023 63 Male B. pseudomallei Bactrim, ceftazidime T2D Survivor
 M024 44 Male B. pseudomallei Meropenem T2D, RF Survivor
 M025 57 Male B. pseudomallei Ceftazidime T2D Survivor
 M026 48 Male B. pseudomallei Ceftazidime, doxycycline, bactrim T2D Survivor
 M027 44 Male B. pseudomallei Ceftriaxone, ceftazidime, meropenem ARF Survivor
 M028 70 Male B. pseudomallei Ceftazidime, levofloxacin, bactrim T2D Survivor
 M029 50 Male B. pseudomallei Ceftriaxone, ceftazidime CRF Non-survivor
 M030 44 Male B. pseudomallei Ceftazidime, ceftriazone T2D, tuberculosis Survivor

*Hospital-acquired septicemia;†long hospitalization;‡taken immunosuppressive drugs;§dialysis; community-acquired septicemia; ¥mechanical ventilation; ¤wounds. #Positive by two sets of blood cultures. ARF, acute renal failure; CRF, chronic renal failure; RF, renal failure; T2D, type 2 diabetes.